Previous 10 | Next 10 |
Biocept, Inc . (NASDAQ: BIOC) (“Biocept” or the “Company”), a leading provider of molecular diagnostic assays, products and service, announces the pricing of an underwritten public offering of 1,176,470 shares of its common stock (or pre-funded warrants in lieu there...
2023-05-24 08:38:01 ET CohBar ( CWBR ) -22% . HeartCore Enterprises ( HTCR ) -21% . Navitas Semiconductor Corporation NVTS -20% commences $80M public offering . PTC Therapeutics PTCT -19% abandons preclinical gene therapy programs, cuts staff; C...
2023-05-23 08:45:00 ET Biocept ( BIOC ) 10% . Microvast Holdings ( MVST ) -20% plunges as Energy Department said to cancel DoE contract. Wave Life Sciences ( WVE ) -13% crashes on decision to drop neurology asset on trial setback. ToughBuilt I...
2023-05-19 12:49:26 ET Gainers: Mallinckrodt ( MNK ) +251% . Biocept ( BIOC ) +47% . WISeKey International Holding ( WKEY ) +41% . Aemetis ( AMTX ) +33% . Crescera Capital Acquisition ( CREC ) +32% . Stereotaxis ( STXS ) ...
Biocept, Inc. (NASDAQ: BIOC) is one of today's top gainers. The company's shares are currently up 64.54% on the day to $9.03. Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assa...
2023-05-17 12:56:05 ET Gainers: Immutep Limited ( IMMP ) +114% . WeTrade Group ( WETG ) +56% . Smart for Life ( SMFL ) +56% . National Western Life Group ( NWLI ) +40% . Bausch Health Companies ( BHC ) +37% . SelectQuote ( ...
2023-05-17 08:14:58 ET Biocept ( NASDAQ: BIOC ) said it has undertaken a 1-for-30 reverse stock split and the common shares will begin trading on a split-adjusted basis on Tuesday market open. The SA Quant Rating on BIOC is Strong Sell , while the average Wall Street A...
Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces that as a result of its 1-for-30 reverse stock split that became effective at 4:05 p.m. Eastern Time on May 16, 2023, its common stock will begin trading on a split-adjusted basis w...
2023-05-10 17:10:18 ET Biocept press release ( NASDAQ: BIOC ): Q1 GAAP EPS of -$0.41. Revenue of $0.7M (-96.5% Y/Y) misses by $0.88M . Research and development expenses for the first quarter of 2023 were $1.0 million, compared with $1.8 million for the first quarte...
Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, reports financial results for the three months ended March 31, 2023 and provides a business update. “I’m exceptionally pleased with the progress being made with our FORESEE ...
News, Short Squeeze, Breakout and More Instantly...
2023-10-18 12:14:27 ET DENVER, Colo., Oct. 18, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Treasure Global Inc (NASDAQ: TGL), SeaStar Medical Holding Corp (NASDAQ: ICU), Mainz Biomed NV (NASDAQ...
Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, announces the full enrollment of 40 subjects with breast or non-small cell lung cancer (NSCLC) who have suspicious or confirmed leptomeningeal metastases (LM) in the feasibility phase of its ...
2023-09-10 08:02:00 ET Why Penny Stocks Could Be a Good Choice for New Investors Penny stocks, typically priced below $5 per share, offer a myriad of advantages for new investors venturing into the world of stock trading. One of the most appealing aspects of trading penny stocks is ...